Cost and Duration of Clinical Trials in Drug Development by Japanese Pharmaceutical Companies

This study quantifies the costs and durations incurred by Japanese pharmaceutical companies in conducting clinical trials, revealing the high costs associated with projects targeting approval involving the USA or Europe. The findings highlight the substantial investments required by the Japanese pharmaceutical industry to bring new drugs to the global market.